๐Ÿ”Ž Trials Near Me

Home โ€บ Lung Cancer

Lung Cancer clinical trials recruiting in the U.S.

348 studies for Lung Cancer are recruiting participants at sites across the United States.

Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.

Cities with the most studies

By state

Recently updated studies

Evaluation for NCI Surgery Branch Clinical Research Protocols

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT00001823

Prospective Multiomic Analysis in Small-Cell Lung Cancer

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07795411

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

RecruitingObservational study
Ages 2 to 120 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT00242723

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT04991025

Smoking Cessation CM for Veterans With or at Risk for Cancer

RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT06432985

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecruitingPhase 1/2
Ages 12 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT04585750

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

RecruitingObservational study
Ages 2 to 100 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT01950572

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07059884

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

RecruitingPhase 1
Ages 18 to 120 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT06885697

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT05334069

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

RecruitingObservational study
Ages 3 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT01441089

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06918132

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT07286149

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

RecruitingPhase 3
Ages 70 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT04181060

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06625775

Empathic Communication Skills (ECS) Training

RecruitingHealthy volunteers welcome
Ages 18 to 100 ยท All sexes ยท Updated Oct 1, 2026 ยท NCT05456841

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 30, 2026 ยท NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 29, 2026 ยท NCT06881784

DK222 Study at Hopkins

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 29, 2026 ยท NCT07140315

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.